Moderna CFO Jorge Gomez Leaves Company As Former Employer Discloses Internal Investigation

Moderna, Inc. (MRNA) announced its Chief Financial Officer, Jorge Gomez, has departed the company, effective immediately. The company's recently retired Chief Financial Officer, David Meline, will continue in his role of Chief Financial Officer while Moderna reopens search for a new CFO.

Moderna noted that the announcement follows the public disclosure by Dentsply Sirona of an ongoing internal investigation into certain matters, including financial reporting. Jorge Gomez served as Executive Vice President & Chief Financial Officer at Dentsply Sirona, Inc. (XRAY) since August 2019. As the investigation is ongoing, Dentsply Sirona was also unable to file its Form 10-Q for the three months ended March 31, 2022, on a timely basis.

At Dentsply Sirona, Jorge Gomez was responsible for leading the global finance organization, including strategic finance, FP&A, Accounting, Treasury, Tax, Corporate Audit and Investor Relations, and the Information Technology function.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Bryant Ranch Prepack Inc. is recalling certain Morphine Sulfate Extended-Release Tablets citing incorrect labeling, the U.S. Food and Drug Administration said. The recall involves one lot of Morphine Sulfate 30 mg Extended-Release tablets, and one lot of Morphine Sulfate 60 mg Extended-Release tablets to the consumer level. The Federal Trade Commission or FTC, has sued Walmart for allowing its money transfer services to be used by fraudsters, who fleeced consumers out of hundreds of millions of dollars. The retail giant is alleged to have looked the other way to pocket millions in fees while scammers took advantage of its failure to properly secure the money transfer services offered at Walmart stores. Home improvement retailer Bed Bath & Beyond, Inc. (BBBY) reported on Wednesday a net loss for first quarter that sharply widened from last year, hurt by hefty transient costs related to inventory markdown reserves and port-related supply chain fees. Both adjusted loss per share and net sales missed analysts' expectations.
Follow RTT